Position in GPCR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,198,707
+$2,219,507 QoQ
Shares Held
107,857
+1.4% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jump Financial, LLC holds $252,934,314 across 133 Biotechnology names. GPCR ranks #15 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
206,675 | $15,519,225 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
291,488 | $11,726,562 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
507,828 | $11,050,335 | |
| 4 | DAWN |
Day One Biopharmaceuticals, Inc.
|
497,365 | $10,663,505 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
504,143 | $10,561,795 | |
| 6 | LEGN |
Legend Biotech Corp
|
516,633 | $9,345,890 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
155,776 | $9,058,374 | |
| 8 | BNTX |
BioNTech SE
|
79,189 | $7,038,317 |
All Filings in GPCR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,198,707 | 107,857 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $2,979,200 | 106,400 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,311,472 | 63,234 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $531,587 | 30,710 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,474,795 | 63,020 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||